Typhoid Fever Market Size, Share, Industry, Forecast and Outlook 2023-2030

Typhoid Fever Market Related Reports:

Global Typhoid Fever Market Surpasses US$ YY Billion in 2022, Projected to Reach US$ YY Billion by 2030

Industry Insights and Future Trends

The Global Typhoid Fever Market has witnessed significant growth, reaching a valuation of US$ YY billion in 2022, with a projected surge to US$ YY billion by 2030. This growth is anticipated to be propelled by a Compound Annual Growth Rate (CAGR) of YY% during the forecast period from 2023 to 2030.

Typhoid Fever Market Dynamics and Scope

The market primarily revolves around treatments, vaccinations, and diagnostics for typhoid fever, caused by the bacterium Salmonella Typhi. With a focus on enhancing sanitation, hygiene, and immunization coverage, global initiatives by governments and international organizations are driving the demand for typhoid-related products.

Key Metrics

Forecast Period: 2023-2030

Size Available for Years: 2021-2030

Segments Covered: Type, Route of Administration, End-users

Regions Covered: North America, Europe, Asia-Pacific, South America, and Middle East & Africa

Fastest Growing Region: Asia-Pacific

Largest Region: North America

Report Insights: The comprehensive market report includes Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and other key insights.

To know more insights Download Sample

Key Developments in Typhoid Fever Market

Increasing Vaccination Program (July 2023): The Ministry of Health and Medical Services (MHMS) of Fiji launched a mass vaccination program against typhoid, aiming to immunize every individual between 9 months and 65 years in the Northern Division. The Ty-FIVE project, directed by the International Vaccine Institute (IVI), collaborates with Fijian MHMS and scientists to evaluate the effectiveness of prophylactic immunization.

The Increasing Prevalence of Typhoid Fever: In the US, approximately 5,700 cases of typhoid fever are reported annually, with up to 75% contracted during international travel. Globally, it affects around 21.5 million people yearly, with symptoms such as high fever, weakness, headaches, and gastrointestinal issues.

Government Initiatives (September 2022): In Quetta, Pakistan, an anti-typhoid campaign targeted 856,000 children aged nine to fifteen in the first phase, emphasizing the preventive nature of vaccination. PHC Global collaborates with the provincial government to raise awareness and promote the typhoid vaccine program.

Increasing Research Activities: Experts are evaluating risk factors, including vaccine hesitancy and access, to enhance prevention and response efforts for drug-resistant typhoid in Pakistan. The Pakistan Field Epidemiology Training Program is being equipped with skills for monitoring and outbreak response.

Vaccine Hesitancy: Despite vaccination availability, hesitancy arises from misinformation, lack of trust in healthcare systems, cultural norms, and concerns about vaccine safety. Addressing hesitancy is crucial for effective typhoid prevention.

Side Effects of Typhoid Vaccine: Both oral Ty21a and injectable Vi polysaccharide vaccines are generally safe but may cause minor, transient side effects. Adverse reactions are rare but can include allergic reactions, necessitating emergency medical attention.

Geographical Penetration

Asia Pacific emerges as a dominant force in the global typhoid fever market, particularly in India, where typhoid is endemic due to insufficient sanitation and hygiene. Varying incidence rates across states and areas contribute to the region's significance in the market.

Key Market Players

Major global players include Emergent, Bharat Biotech, Bio Med, GlaxoSmithKline plc., Sanofi, and Merck & Co., Inc., among others.

Conclusion

The Global Typhoid Fever Market is poised for substantial growth, driven by increasing awareness, vaccination programs, and government initiatives. The market's dynamics underscore the critical importance of preventive measures and ongoing research to combat the prevalence of typhoid fever worldwide.

Related reports:

Classical Swine Fever Vaccines Market

Conjugate Vaccines Market

Live Attenuated Vaccines Market

Varicella Attenuated Live Vaccine Market

H1N1 (Swine Flu) Vaccination Market

Vaccine Delivery Devices Market

About Us -

DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

Contact Us -

Name: Sai K

Designation: Sales & Senior Business Consultant

Email: info@datamintelligence.com

Phone: +1 877 441 4866

Website: https://www.datamintelligence.com